This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT07722026
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- HUINNO Co., Ltd
- Registry
-
NCT07722026
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT07722026. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-01 (actual); primary completion 2022-07-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient
- Condition
- Suspected Arrhythmia
- Condition
- Palpitations
- Condition
- Dizziness
- Condition
- Cryptogenic Ischemic Stroke
- Condition
- Transient Ischemic Attack
- Intervention (Device)
- MEMO Patch V2
- Intervention (Device)
- 24-Hour Holter Monitor
- Lead sponsor
- HUINNO Co., Ltd
Record details
- Record id
cardio:ct-nct07722026- Content hash
ae83d40270765ae29a13670b2f03c1c32f01f3ff4af2f64b936895b6a283f54b